Controversies in the use of nevirapine for prevention of mother-to-child transmission of HIV

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.6, 2006-04, pp. : 677-685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiretroviral Therapy for Prevention of Mother-to-Child HIV Transmission: Focus on Single-Dose Nevirapine

By Giaquinto Carlo

Clinical Drug Investigation, Vol. 26, Iss. 11, 2006-01 ,pp. : 611-627

Adis International

Access to resources Recommend Favorite

New hope in the prevention of mother-to-child transmission of HIV

Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Nevirapine regimens best value for mother-to-child HIV prevention

Inpharma, Vol. 1, Iss. 1532, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Nevirapine regimens best value for mother-to-child HIV prevention

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 500, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

South Africa is likely to withdraw approval of nevirapine in the prevention of mother-to-child transmission (MTCT) of HIV infections unless Boehringer Ingelheim produces new data to support the use of the drug in this indication

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 425, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite